DE3315974C2 - - Google Patents
Info
- Publication number
- DE3315974C2 DE3315974C2 DE19833315974 DE3315974A DE3315974C2 DE 3315974 C2 DE3315974 C2 DE 3315974C2 DE 19833315974 DE19833315974 DE 19833315974 DE 3315974 A DE3315974 A DE 3315974A DE 3315974 C2 DE3315974 C2 DE 3315974C2
- Authority
- DE
- Germany
- Prior art keywords
- solution
- eye
- potassium
- toned
- eyes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000243 solution Substances 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 23
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 17
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 239000001103 potassium chloride Substances 0.000 claims description 9
- 235000011164 potassium chloride Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 239000012487 rinsing solution Substances 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 description 13
- 241000219739 Lens Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 6
- 238000002386 leaching Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 4
- 229910001414 potassium ion Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
- 206010013774 Dry eye Diseases 0.000 description 3
- 208000019025 Hypokalemia Diseases 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 208000007645 potassium deficiency Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000882 contact lens solution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 1
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 1
- 241000885882 Tarzetta cupularis Species 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- -1 diffusion Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000027720 dry mucous membrane Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000144985 peep Species 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000006426 vascular sprouting Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Detergent Compositions (AREA)
- Eyeglasses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833315974 DE3315974A1 (de) | 1983-05-02 | 1983-05-02 | Sterile, osmotische neutrale salzloesung zum schnellen und gruendlichen auslaugen und abschwemmen der schaedlichen desinfektionschemikalien aus dem material der hydroweichen kontaktlinsen unmittelbar vor dem einsetzen |
CH209884A CH666755A5 (de) | 1983-05-02 | 1984-04-30 | Kontaktlinsenspuelloesung zum nachbehandeln von hydroweichen kontaktlinsen. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833315974 DE3315974A1 (de) | 1983-05-02 | 1983-05-02 | Sterile, osmotische neutrale salzloesung zum schnellen und gruendlichen auslaugen und abschwemmen der schaedlichen desinfektionschemikalien aus dem material der hydroweichen kontaktlinsen unmittelbar vor dem einsetzen |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3315974A1 DE3315974A1 (de) | 1984-11-08 |
DE3315974C2 true DE3315974C2 (enrdf_load_stackoverflow) | 1991-10-31 |
Family
ID=6197940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19833315974 Granted DE3315974A1 (de) | 1983-05-02 | 1983-05-02 | Sterile, osmotische neutrale salzloesung zum schnellen und gruendlichen auslaugen und abschwemmen der schaedlichen desinfektionschemikalien aus dem material der hydroweichen kontaktlinsen unmittelbar vor dem einsetzen |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH666755A5 (enrdf_load_stackoverflow) |
DE (1) | DE3315974A1 (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011593A1 (en) * | 1993-10-29 | 1995-05-04 | Mats Ersson | Cleaning solution |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3318211A1 (de) * | 1983-05-19 | 1984-11-22 | Bruno 6000 Frankfurt Koller | Kontaktlinsenpflegemittel, welche schnell und zuverlaessig die desinfektionschemikalien an eine auslaugloesung abgeben |
DE3926003C2 (de) * | 1989-08-05 | 1994-04-28 | Bruno Koller | Aufbewahrungslösung und Pflegeverfahren für weiche Kontaktlinsen |
DE3936765C2 (de) * | 1989-08-05 | 1998-10-01 | Bruno Koller | Wässriger Kontaktlinsenreiniger, Verfahren zum Pflegen von Kontaktlinsen und Verwendung des Reinigers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3908680A (en) * | 1973-10-12 | 1975-09-30 | Flow Pharma Inc | Methods for cleaning and bleaching plastic articles |
-
1983
- 1983-05-02 DE DE19833315974 patent/DE3315974A1/de active Granted
-
1984
- 1984-04-30 CH CH209884A patent/CH666755A5/de not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011593A1 (en) * | 1993-10-29 | 1995-05-04 | Mats Ersson | Cleaning solution |
Also Published As
Publication number | Publication date |
---|---|
CH666755A5 (de) | 1988-08-15 |
DE3315974A1 (de) | 1984-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68927631T2 (de) | Wässrige Augenlösung und Verfahren zur Konservierung derselben | |
DE69513902T2 (de) | Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit | |
DE60203691T3 (de) | Verwendung von Dexpanthenol in Kontaktlinsenpflegezusammensetzungen | |
DE2339867C2 (de) | Wäßrige Reinigungs-, Lagerungs- und Befeuchtungslösung für Kontaktlinsen | |
DE69232885T2 (de) | Wässrige Desinfizierungslösung für weiche Kontaktlinsen, Verfahren zur Desinfizierung weicher Kontaklinsen, und preservierte Lösung opthalmischer Arzneimittel | |
Kompa et al. | Comparison of emergency eye-wash products in burned porcine eyes | |
CA2701721C (en) | Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid | |
DE2810978A1 (de) | Reinigungsmittel, insbesondere in tablettenform fuer weiche kontaktlinsen | |
IL112674A (en) | Sustained release liquid aqueous ophthalmic delivery system and liquid aqueous ophthalmic pharmaceutical composition both containing the polymer chitosan | |
DE10161149B4 (de) | Verwendung von Heparin-haltigem Ophthalmikum | |
DE1300636B (de) | Mittel zum Benetzen von Kontaktlinsen | |
DE3315974C2 (enrdf_load_stackoverflow) | ||
DE102005055275A1 (de) | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung | |
DE2854278C2 (enrdf_load_stackoverflow) | ||
DE60319133T2 (de) | Zusammensetzungen, die n-isopropylacrylamid umfassen, sowie verfahren zur hemmung der proteinabsorption an oberflächen | |
DE69119707T2 (de) | Einstufiges verfahren zur konservierung von kontaktlinsen | |
Giannaccare et al. | A novel osmoprotectant tear substitute for the treatment of dry eye disease | |
DE60119337T2 (de) | Aseptische mittel | |
DE2719770B2 (de) | Verwendung von Kollagenen zur Herstellung von ophthalmischen pharmazeutischen Zusammensetzungen mit langsamen Freigabeeigenschaften | |
DE3000742A1 (de) | Verfahren und mittel zur behandlung von kontaktlinsen | |
DE3526125A1 (de) | Reiniger fuer harte und weiche kontaktlinsen | |
US20080152669A1 (en) | Method of Stimulating the Production of Mucin in the Eye of a Patient | |
RU2755298C1 (ru) | Раствор для ухода за контактными линзами | |
DE3625867C2 (de) | Verwendung von Tetrachlordecaoxid in der Ophthalmologie | |
DE3936765C2 (de) | Wässriger Kontaktlinsenreiniger, Verfahren zum Pflegen von Kontaktlinsen und Verwendung des Reinigers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8127 | New person/name/address of the applicant |
Owner name: KOLLER, BRUNO, 6470 BUEDINGEN, DE |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8320 | Willingness to grant licenses declared (paragraph 23) |